Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CervoMed (CRVO) Depreciation & Amortization (CF) (2022)

Historic Depreciation & Amortization (CF) for CervoMed (CRVO) over the last 6 years, with Q4 2022 value amounting to -$883995.0.

  • CervoMed's Depreciation & Amortization (CF) changed N/A to -$883995.0 in Q4 2022 from the same period last year, while for Sep 2023 it was -$883995.0, marking a year-over-year decrease of 23481.74%. This contributed to the annual value of $93416.0 for FY2021, which is 945.25% down from last year.
  • Per CervoMed's latest filing, its Depreciation & Amortization (CF) stood at -$883995.0 for Q4 2022.
  • CervoMed's Depreciation & Amortization (CF)'s 5-year high stood at -$883995.0 during Q4 2022, with a 5-year trough of -$883995.0 in Q4 2022.